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Abstract
Background: The high polymorphism rate in the human ABO blood group gene seems to be
related to susceptibility to different pathogens. It has been estimated that all genetic variation
underlying the human ABO alleles appeared along the human lineage, after the divergence from the
chimpanzee lineage. A paleogenetic analysis of the ABO blood group gene in Neandertals allows us
to directly test for the presence of the ABO alleles in these extinct humans.
Results: We have analysed two male Neandertals that were retrieved under controlled conditions
at the El Sidron site in Asturias (Spain) and that appeared to be almost free of modern human DNA
contamination. We find a human specific diagnostic deletion for blood group O (O01 haplotype)
in both Neandertal individuals.
Conclusion: These results suggest that the genetic change responsible for the O blood group in
humans predates the human and Neandertal divergence. A potential selective event associated with
the emergence of the O allele may have therefore occurred after humans separated from their
common ancestor with chimpanzees and before the human-Neandertal population divergence.
Background
The ABO blood group system was the first genetic poly-
morphism discovered in humans. It consists of three alle-
les: two co-dominant A and B alleles, and one silent and
recessive O allele[1]. The system is controlled by a single
gene at the ABO locus. This gene encodes a glycosyltrans-
ferase enzyme that adds a sugar residue to a carbohydrate
structure known as the H antigen, that is present in the
membrane of red cells as well as most epithelial and
endothelial cells. The A allele codes for an enzyme that
adds a N-acetyl galactosamine to the H antigen, while the
B allele, which differs from the former by four amino acid
changes, codes for an enzyme that adds a D-galactose. The
O allele occurs most frequently in modern humans and
carries a human-specific inactivating mutation which pro-
duces a non-functional enzyme, and thus the H antigen
remains without further modification on the surface of
the cells [2,3]. The combination of the three ABO alleles
results in four major phenotypes, named A, B, AB and O,
these carry different antigens (A, B, both and neither,
respectively) that react with specific antibodies [1].
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The ABO gene is organized in 7 exons that range in size
from 28 to 688 nucleotides, with exon 6 and 7 being the
largest [2,4]. Further analyses of the ABO gene have
shown that, at the nucleotide sequence level, numerous
haplotypes exist among modern humans[5]. The main A
and B alleles (hereafter A101 and B101, respectively) dif-
fer by four amino acid changes at positions 176, 235, 266
and 268 (nucleotide positions are numbered starting
from the first nucleotide of exon 1), with the two later
being determining the A and B specificity of the enzyme.
The most frequent among all human ABO alleles is the O
allele [6]. The most frequent O haplotypes, O01 and O02,
share a single G nucleotide deletion in position 261 of
exon 6 (Δ261) that creates a premature stop codon and
results in a truncated protein with no enzymatic activity
[7]; they are referred as the O (Δ261) alleles below. The
O01 haplotypes differ from the O02 haplotypes by at least
six nucleotide substitutions, including position 297 in
exon 6, which is A in the former and G in the latter.
Many studies have examined the association between the
ABO alleles and a variety of diseases [8], mainly focussed
on infectious agents that can use the A and B antigens as
receptors, or in case of the O allele, the absence of the A
and B antigens. The O allele can provide a selective advan-
tage since it also produces both anti-A and anti-B antibod-
ies [9]. In particular, it has been suggested that the O allele
protects against severe malaria [10]. At the same time, it
can be more sensitive to Helicobacter pylori infections [11]
and to severe forms of cholera [12]. The complex pattern
of putative selective agents favouring or acting against dif-
ferent alleles could explain the maintenance of the high
ABO polymorphism [13], as evidenced by the signal of
balancing selection detected on the gene [14,15]. There-
fore studying the evolution of the ABO blood groups to
determine when during human history the different alle-
les emerged may contribute to our understanding on what
selective forces might have worked on the different alleles.
Within the apes a convergent evolution of the different
blood groups can be observed, although no ape displays
all three phenotypes known in humans [3]. Whereas all
gorillas studied to date carry only an allele that has prop-
erties similar to the human B allele, our closest living rel-
ative, the chimpanzee carries two alleles corresponding to
the human A and O. Both alleles in the chimpanzee are
characterized by species specific mutations in the ABO
gene that are distinct from those found in humans [3]. For
the ABO alleles on the human lineage it has been esti-
mated that the B101 allele, which gave rise to all the B var-
iants, derived from the ancestral A101 allele around 3.5
million years ago (Mya) [14], whereas the youngest and
most common human allele O01, carrying the Δ261 dele-
tion, derived from the A allele only about 1.15 ± 0.2 Mya
determined by coalescence analysis [15]. The emergence
of the ABO allele O01 therefore predates the mean diver-
gence time for modern humans and Neandertals esti-
mated to more than 500 Kya [16,17] and opens the
possibility to put a lower limit on the estimated coales-
cence date by directly testing for the presence of the O01
allele in the Neandertal population. Thus we undertook a
targeted approach to determine whether the Δ261 dele-
tion in the O allele was also present in Neandertals and by
that testing the emergence of the O01 allele in the com-
mon ancestor of modern human and Neandertal.
Methods
DNA extraction and amplification
We analysed two Neandertal samples from the El Sidrón
site (Asturias, Spain) [18-20] that were extracted in 2006
under controlled conditions (with excavators completely
outfitted in sterile lab gear, including coveralls, face mask,
face shield and gloves)[21] and immediately frozen, prior
to sending them to the dedicated ancient DNA laborato-
ries in both Barcelona and Leipzig, where DNA extractions
were performed. About 500 mg of cortical bone was
removed, powdered and extracted as described [20,22].
Analysis of specific nuclear DNA loci from ancient Nean-
dertal remains by the polymerase chain reaction (PCR) is
a challenging task that presents two main limitations: the
small quantity and short length of ancient DNA fragments
due to the degradation of the original template molecules
and the difficulty in distinguishing between endogenous
Neandertal DNA and putative contemporary modern
human contaminants. However, the presence of single
informative substitutions in the ABO gene allows for char-
acterization of the different alleles even when retrieving
short DNA sequences. Also, the co-amplification of mito-
chondrial DNA (mtDNA) and nuclear markers allow us to
control for the presence of human contamination in the
extracts.
Two-step multiplex PCRs [23] in a total volume of 20 μl
were set up and incubated for 10 minutes at room temper-
ature with 0.5 units of Shrimp Nuclease (Biotec Phar-
macon®) to degrade any double-stranded DNA that may
contaminate the reagents [24]. After inactivating the
nuclease for 30 minutes at 65°C, 5 μl of extract and Taq-
Gold DNA polymerase were added to the PCR. Twenty-
seven cycles of PCR were performed in the first PCR and
33 cycles in the second PCR. Reaction conditions were as
described [24] except for the annealing temperature,
which was 53–55°C, depending on the primers used.
The informative Δ261 position in exon 6 was amplified
with the F20144-AGGAAGGATGTCCTCGTGG, R20163-
TGCCCTCCCAGACAATGG primer couple (numbered
according to the GenBank RefSeq AY268591). The 297
position in exon 6, further retrieved to determine to whichBMC Evolutionary Biology 2008, 8:342 http://www.biomedcentral.com/1471-2148/8/342
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of the two main O haplotypes (O01 or O02) the speci-
mens belonged, was amplified with the F20173-TTGGCT-
GGCTCCCATTGTCTGG, R20194-
GAACTGCTCGTTGAGGATG primer couple. The PCR
products were 55 and 61 bp in length, respectively. In Bar-
celona, amplification products of the correct size were
cloned using the TOPO TA cloning kit (Invitrogen), and
several clones from each product were sequenced using an
ABI3730 capillary sequencer (Applied Biosystems) fol-
lowing the manufacturer's instructions. In Leipzig, the
products from each PCR were pooled and ligated with a
specific tagging sequence for each PCR as described [25]
and subsequently sequenced on a 454 FLX machine.
Contamination controls
To determine the degree of modern human contamina-
tion in the Neandertal DNA extracts we amplified and
sequenced, using conserved primers, one position in the
mitochondrial DNA (mtDNA) coding region (diagnostic
transversion 6,267) from each Neandertal extract where
Neandertals were found to be distinct from modern
humans [17], as well as two diagnostic mtDNA Hypervar-
iable Region I (HVR1) fragments between positions
16,135–16,169 and 16,182–16,223. To ensure that the
copy number of nuclear DNA is sufficient for amplifying
nuclear Neandertal DNA and to monitor potential nuclear
DNA contamination we additionally amplified a control
position on the Y-chromosome, which was previously
described as ancestral in both specimens and defines the
deepest clade in the human Y-chromosome tree (Y2 in
[24]). This clade is comprised of all modern human Y
chromosomes haplogroups outside Africa. Successful
amplifications of the Y chromosomal control fragment
confirmed that the two specimens labeled 1253 and
1351c come from two different male individuals [24].
Results and discussion
In Barcelona, position 261 on exon 6 in the 1253 speci-
men was amplified in four independent PCRs in parallel
with the mtDNA controls (diagnostic transversion 6,267
and mtDNA HVR1 fragments) and the nuclear Y-chromo-
some position. The products were cloned and at least 10
clones sequenced. The sequences from all four products
for the 1253 specimen (n = 53) showed the Δ261 dele-
tion, which defines the O alleles. All Y2 sequences (n = 8)
were found to be ancestral (i.e., identical to the chimpan-
zee sequence), while 35 out of 36 mtDNA sequences were
Neandertal-specific. We further amplified and sequenced
position 297 on exon 6. Twelve sequences display an A at
position 297, which is compatible with the most frequent
O haplotype, the O01, but not with the other, the O02
[5]. The position 261 on exon 6 was also amplified in four
independent PCRs from the specimen 1351c along with
the Y2 fragment and the informative mtDNA position
6,267. All the ABO sequences (n = 55) were identical to
those found in the 1253 specimen, while all Y2 sequences
(n = 4) were ancestral, and 35 out of 36 mtDNA sequences
were Neandertal specific (Table 1).
In Leipzig, position 261 and position 297 on exon 6 in
specimen 1253 were amplified in two independent 2-step
Multiplex PCRs together with one of the informative
mtDNA fragments (position 6,267). All sequences for the
261 fragment in the first PCR show Δ261 (n = 40), for 20
of the sequences we find a additional C > T substitution at
position 263, a substitution at that position was not
found in any other PCR product from Leipzig or Barce-
lona and is likely to derive from a miscoding lesion caused
by deamination of cytosine on the ancient molecule
[26,27]. For the second PCR from specimen 1253, 39
sequences were found to carry the Δ261 and 21 displayed
a G at that position (Table 1). At position 297 an A was
found in all clones from the first PCR, while in the second
Table 1: Sequencing results for the 1253 and 1351c Neandertal specimens, with ABO polymorphic positions.
Sample PCR Δ261 261G 297A 297G Y2 An 6,267 Ne 6,267 MH HVR1 Ne HVR1 MH
1253 1B 15 0 12 0 8 - - - -
1253 2B 10 0 - - - 15 1 9 0
1253 3B 15 0 - - - - - 12 0
1253 4B 13 0 - - - - - - -
1253 1L 39 21 5 0 - 188 29 - -
1253 2L 40 0 49 21 - 146 32 - -
1351c 1B 10 0 Na Na 4 - - - -
1351c 2B 10 0 - - - 13 1 - -
1351c 3B 16 0 - - - - - - -
1351c 4B 19 0 - - - - - - -
1351c 1L Na Na 50 0 - 191 31 - -
1351c 2L 43 41 41 0 - 186 26 - -
(Δ261): deletion in position 261. (261G): G in position 261. (297A): A in position 297. (297G): G in position 297. (Y2): Y chromosome basal marker. 
(An): ancestral. (nt 6,267): mtDNA nucleotide position 6,267. (Ne): Neandertal. (MH): Modern human. (HVR1): mtDNA hypervariable region 1. 
(B): Barcelona; (L): Leipzig. (Na): no amplification product obtained. (-): no amplification attempted.BMC Evolutionary Biology 2008, 8:342 http://www.biomedcentral.com/1471-2148/8/342
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PCR most of the sequences (n = 49) display an A and oth-
ers (n = 21) a G (Table 1). For specimen 1351c, just one
PCR resulted in a product covering position 261 where
some sequences displayed the Δ261 (n = 43) and some
showed no deletion (n = 41). All the sequences (n = 50
and 41) in the two independent PCRs for specimen 1351c
showed an A at position 297.
Between 82% and 85% Neandertal sequences were found
for the informative mtDNA fragments that were co-ampli-
fied along the ABO positions. Despite the informative
transversion at position 6,267 where humans have a A
and Neandertals a C, there is a second diagnostic position,
6,261, present in that fragment where most humans have
a G and Neandertals an A [17]. All clones for the mtDNA
fragments show either the 6,267A-6,261G or the 6,267C-
6,261A haplotype, allowing to determine whether they
derived from human or Neandertal, respectively. There is
also a number of transitions present in a minority of the
mtDNA sequences that are almost all either C > T or G >
A substitutions typical for miscoding lesions [26,27]. Fur-
thermore we find a number of insertions and deletions
close to homopolymers, a known problem of the 454
technology [17]. Only little post-mortem damage was
found in the nuclear sequences retrieved in Leipzig and
Barcelona (see Additional File 1, Table S1), which can be
attributed to the small number of individual clone
sequences obtained, the short length of the amplified
product and a low molecule starting number for the PCR.
The later explanation is supported by some unsuccessful
amplifications in both Barcelona and Leipzig, and also by
the almost equal ratio of clones that show the C > T tran-
sition at position 263 for one of the 261 fragments, sug-
gesting the PCR started only from two initial DNA
molecules (see Additional File 1 Table S1).
The low level of modern human mtDNA contamination
and the fact that from both specimens ancestral Y chro-
mosomal positions could be repeatedly retrieved suggest
that the majority of the ABO fragments amplified in this
study derive from Neandertal nuclear DNA. Since nine
out of eleven successful amplifications of position 261
from both Neandertals only displayed the informative
deletion for allele O, we conclude that this allele was
present in the Neandertal population. Since four out of
five amplifications of position 297 only displayed an A at
that position, it is likely that the haplotype was O01. If we
assume that our amplifications just start from single mol-
ecules and that our Neandertals are heterozygous at posi-
tion 261, it seems quite unlikely to observe only one of six
and one of five PCRs for the second individual without
the Δ261 (1253 p = 0.093; 1351c p = 0.15). Given an aver-
age contamination rate of 9.7% with a probability of car-
rying either the A or the B allele of 0.7 (estimated from the
current European population) the chances of this observa-
tion would increase (1253 p = 0.29; 1351c p = 0.25).
Conclusion
Our results indicate that the two El Sidrón Neandertal
individuals were most likely homozygous for the O01
allele. Nevertheless given a low rate of potential modern
human contaminants in an unknown allelic state, we can-
not discard the possibility that both Neandertals could
have been heterozygous (e.g. OA or OB). The results how-
ever suggest the presence of the human O01 allele already
in the common ancestor of Neandertals and modern
humans and thereby confirming an emergence of the O01
allele more than 1 Mya predating the divergence of the
modern human and Neandertal populations. An alterna-
tive possibility would be that Neandertals have acquired
this allele by gene flow from modern humans, although at
present, other genetic evidences suggest that this scenario
is unlikely [17,24]. Furthermore a potentially
homozygous state in at least two Neandertals, even
though from the same group, at least indicates that a
potential selective advantage of the O allele could have
also been present in the Neandertal population. Future
analyses regarding the frequency of the ABO alleles will be
necessary to reveal if all three genotypes were conserved in
the Neandertal population.
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